CollPlant Set to Showcase Innovations at the 2025 Global Biofabrication Conference
CollPlant's Upcoming Presentation at the 2025 International Conference on Biofabrication
CollPlant Biotechnologies, listed on the Nasdaq under the ticker CLGN, is a pioneering entity in the fields of regenerative and aesthetic medicine. The company is driven by its mission to innovate through advanced technologies and products, particularly focusing on its unique non-animal-derived recombinant human collagen (rhCollagen). As part of its efforts to advance the field of biofabrication, CollPlant has announced its upcoming participation in the 2025 International Conference on Biofabrication, which will take place from September 14 to 17, 2025, in Warsaw, Poland at the iconic Palace of Culture and Science.
Conference Participation Details
CollPlant is set to deliver two key presentations at the conference, showcasing its leading-edge advancements and technological prowess:
- - Presentation Title: “rhCollagen Bioinks for Biofabrication”
Time: 1:30 PM - 3:00 PM
Chair: Yehiel Tal, CEO of CollPlant
- - Presentation Title: “Mechanical Computational Modeling and Simulation of Biodegradable Implants”
Time: 1:50 PM - 2:00 PM
Throughout the conference, attendees can visit CollPlant's exhibition booth. The booth will feature the innovative rhCollagen platform along with various biofabrication applications showcasing the potential of 3D bioprinting in medical research.
Focus on 3D Bioprinting
The field of biofabrication, particularly through technologies like 3D bioprinting, is gaining substantial momentum as researchers look to fabricate complex scaffolds that can be used for tissue and organ engineering. CollPlant’s rhCollagen-based bioinks have key characteristics that make them ideal for high-fidelity 3D printing. These attributes include:
- - Controlled rheology ensuring print precision
- - A safety profile that avoids the use of animal products
- - Biocompatibility to promote tissue integration
- - Tunable mechanical properties that can adapt to specific applications
About the International Society for Biofabrication
The International Society for Biofabrication (ISBF), established in 2010, plays a crucial role in advancing biofabrication research and clinical applications. It hosts the annual International Conference on Biofabrication to provide a platform for experts in the field to share their knowledge and advancements. The conference has grown significantly since its inception, attracting more than 500 participants from a diverse range of countries.
CollPlant’s Commitment to Innovation
CollPlant continues to position itself at the forefront of medical innovation. The company focuses on harvesting the advantages of 3D bioprinting to provide solutions within the realms of tissue repair and medical aesthetics. Its distinctive rhCollagen, engineered through proprietary plant-based genetic technology, enables a myriad of applications across various fields.
According to recent developments, CollPlant has established a partnership with Allergan, an AbbVie company, to enhance the development and commercialization of dermal and soft tissue fillers. This collaboration underscores CollPlant's strength in the regenerative medicine market and further solidifies its reputation as a leader in the biofabrication domain.
Through its presentations and exhibition in Warsaw, CollPlant aims not only to share its innovations but also to foster relationships with industry leaders, researchers, and professionals dedicated to improving regenerative medicine and biofabrication practices. The conference serves as an essential gathering for those at the forefront of these critical medical advancements and technology efforts.
For more details on CollPlant and its cutting-edge initiatives, visit CollPlant’s Website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.